Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients.
Cohen EE, Wu K, Hartford C, Kocherginsky M, Eaton KN, Zha Y, Nallari A, Maitland ML, Fox-Kay K, Moshier K, House L, Ramirez J, Undevia SD, Fleming GF, Gajewski TF, Ratain MJ.
Cohen EE, et al. Among authors: gajewski tf.
Clin Cancer Res. 2012 Sep 1;18(17):4785-93. doi: 10.1158/1078-0432.CCR-12-0110. Epub 2012 Aug 7.
Clin Cancer Res. 2012.
PMID: 22872575
Free PMC article.
Clinical Trial.